Intellia Therapeutics, Inc.
COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY
Last updated:
Abstract:
The present disclosure is directed to genome editing systems, reagents and methods for immunooncology.
Status:
Application
Type:
Utility
Filling date:
7 Jun 2019
Issue date:
29 Apr 2021